A Marseille Researcher Awarded for His Advances Against Cancer
Éric Vivier, a professor of Immunology at Aix-Marseille University and a researcher at the Centre d'Immunologie de Marseille-Luminy (CIML), has just won the prestigious international prize from the ARC Foundation. This award recognizes his groundbreaking research on innate immunity, which is crucial for the development of new immunotherapies. With this honor in the category of "translational and clinical research," he becomes the first researcher from Marseille to receive this recognition, along with a grant of 150,000 euros.
Voir cette publication sur Instagram
Innate Immunity at the Heart of New Cancer Therapies
Éric Vivier focuses on “natural killer” immune cells (or NK cells), known for their ability to naturally eliminate tumor cells. Through advanced molecular analyses, the researcher has shed light on their role in the immune system. His work contributes to the development of next-generation immunotherapies, which precisely target cancer cells while minimizing side effects for patients.
Innovative Therapeutic Antibodies Tested in Clinics
Today, Professor Vivier’s research is moving into the clinical phase. The goal is to develop innovative therapeutic antibodies against cancer, some of which are already in the testing phase.
ssai. These major advancements promise to enhance patient care and offer more effective treatments in the future. It's a source of pride for Marseille, which is establishing itself as a hub for biomedical research on a European scale.
